Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06905314
PHASE1

A Single Ascending Dose of HRS-4029 in Healthy Subjects

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd

View on ClinicalTrials.gov

Summary

The study is being conducted to evaluate the safety, tolerability and pharmacokinetics of HRS-4029 following a single intravenous dose administration in healthy subjects.

Official title: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HRS-4029 Following a Single Dose in Healthy Subjects

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

55

Start Date

2025-04

Completion Date

2025-12

Last Updated

2025-04-01

Healthy Volunteers

Yes

Interventions

DRUG

HRS-4029

HRS-4029

DRUG

Placebo

Placebo

Locations (1)

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China